Susan Tsai Selected Research

Indicators and Reagents (Reagents)

4/2020

Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan Tsai Research Topics

Disease

53	Neoplasms (Cancer) 04/2024 - 07/2009
50	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 07/2010
27	Adenocarcinoma 02/2024 - 07/2010
10	Neoplasm Metastasis (Metastasis) 04/2022 - 05/2010
5	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 10/2013
5	Cholangiocarcinoma 12/2016 - 01/2009
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2014
3	Leiomyoma (Uterine Fibroids) 10/2023 - 01/2018
3	Sarcoma (Soft Tissue Sarcoma) 03/2023 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2019
3	Margins of Excision 04/2020 - 10/2015
3	Fibrosis (Cirrhosis) 10/2015 - 01/2009
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2024 - 11/2021
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 07/2010
2	Carcinoma (Carcinomatosis) 01/2022 - 11/2014
2	Carcinogenesis 01/2022 - 01/2020
2	Adenoma (Adenomas) 01/2022 - 01/2019
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 12/2015
2	Gallstones (Gallstone) 01/2022 - 01/2005
2	Wounds and Injuries (Trauma) 01/2021 - 09/2005
2	Myoma 09/2020 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 06/2014
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Hemorrhage 01/2019 - 01/2018
2	Disease Progression 10/2018 - 01/2018
2	Sinistral Portal Hypertension 05/2014 - 07/2013
2	Weight Loss (Weight Reduction) 03/2014 - 07/2010
2	Obesity 10/2012 - 07/2010
2	Sarcopenia 10/2012 - 07/2011
2	Melanoma (Melanoma, Malignant) 03/2010 - 04/2008
1	Substance-Related Disorders (Drug Abuse) 05/2024
1	Sepsis (Septicemia) 05/2024
1	Cholangitis 05/2024
1	Surgical Wound Infection 05/2024
1	Abdominal Aortic Aneurysm 03/2024
1	Endometriosis 01/2023
1	Fistula 01/2023
1	Adenomyosis 01/2023
1	Chromosomal Instability (Chromosome Stability) 11/2022

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2014
4	AntigensIBA 01/2021 - 10/2015
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2012
3	N-acetyltalosaminuronic acid (NAT)IBA 12/2023 - 02/2015
3	folfirinoxIBA 05/2023 - 03/2014
3	Gemcitabine FDA Link 05/2023 - 01/2016
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2022
3	CarbohydratesIBA 01/2020 - 10/2015
3	ChemokinesIBA 01/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2022 - 06/2015
2	Chemokine ReceptorsIBA 01/2022 - 01/2014
2	Cell-Free Nucleic AcidsIBA 11/2021 - 10/2015
2	AlbuminsIBA 06/2020 - 06/2018
2	CytokinesIBA 01/2019 - 01/2017
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2017 - 10/2015
2	LigandsIBA 01/2017 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 09/2014
2	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 03/2014
2	Latanoprost (Xalatan)FDA Link 09/2013 - 03/2012
1	Opioid Analgesics (Opioids)IBA 05/2024
1	ErbB Receptors (EGF Receptor)IBA 02/2024
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2024
1	UbiquinoneIBA 02/2024
1	mitoquinoneIBA 02/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2024
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2024
1	130-nm albumin-bound paclitaxelIBA 05/2023
1	PlasticsIBA 03/2023
1	Steroid Receptors (Steroid Receptor)IBA 01/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	devimistatIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Nucleic AcidsIBA 11/2022
1	MutagensIBA 11/2022

Therapy/Procedure

36	Therapeutics 04/2024 - 04/2008
31	Neoadjuvant Therapy 01/2024 - 04/2013
12	Drug Therapy (Chemotherapy) 12/2023 - 10/2012
9	Radiotherapy 01/2023 - 11/2014
7	Pancreaticoduodenectomy 05/2024 - 07/2010
6	Pancreatectomy 03/2024 - 07/2013
5	Liver Transplantation 01/2019 - 07/2009
4	Hepatectomy 03/2021 - 05/2010
3	Precision Medicine 01/2024 - 10/2018
3	Uterine Myomectomy 10/2023 - 01/2018
3	Laparotomy 01/2021 - 05/2014
2	Length of Stay 05/2024 - 07/2011
2	Hysterectomy 10/2023 - 09/2020
2	Adjuvant Chemotherapy 01/2023 - 01/2021
2	Hyperthermic Intraperitoneal Chemotherapy 10/2022 - 01/2019
2	Cytoreduction Surgical Procedures 10/2022 - 01/2019
2	Radiofrequency Ablation 01/2019 - 09/2010
2	Surgical Splenorenal Shunt (Splenorenal Shunt) 01/2019 - 07/2013
2	Operative Time 01/2018 - 07/2010
2	Adjuvant Radiotherapy 01/2018 - 11/2014
2	Contraindications 01/2017 - 05/2014
2	Ligation 05/2014 - 07/2013
2	Transplantation 07/2009 - 01/2009
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2024
1	Pneumonectomy (Lung Volume Reduction) 03/2024
1	Colectomy 03/2024
1	Gastrectomy 01/2023